Table 1 Patient characteristics at baseline
Parameters | Mean ± SE |
|---|---|
Age (years) | 65.4 ± 1.9 |
Male/female | 15:20 |
Duration of diabetes (years) | 20.1 ± 1.8 |
Duration of HD (years) | 3.5 ± 0.4 |
Before treatment (n) | None: 7 |
α-Glucosidase inhibitors: 5 | |
Sulfonylureas: 2 | |
Vildagliptin: 2 | |
Alogliptin: 2 | |
Liraglutide: 4 | |
Insulin: 13 | |
Statins: 9 |